6 TECH OUTLOOKMAY - 2021EditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comThe onset of the COVID-19 pandemic has set many biotech companies in a race to develop vaccines effective against SARS-CoV-2. According to WHO's COVID-19 candidate vaccine landscape and tracker database, more than 100 vaccines are currently being tested in clinical trials, whereas more than 184 are there in the preclinical stages. This data alone points to the fact that the demand for vaccine trials will remain high in the coming years.Notably, the clinical trials space is simultaneously undergoing a paradigm shift. The increasing economic and regulatory pressure is forcing more and more pharmaceutical and biotech companies to outsource their clinical research activities. The service providers are also broadening their scope, from providing limited clinical trial services to offering a diverse range of services, including preclinical evaluations, planning and management, and independent safety data monitoring. The pandemic is also facilitating digitalization in the domain at an unprecedented rate. On that front, artificial intelligence (AI), along with big data, will enable innovations that will fundamentally transform clinical trials, such as the incorporation of phase I and phase II trials, the development of new patient-centered endpoints, and analysis of real-time data. In this edition of Pharma Tech Outlook, we present to you ACM Global Laboratories, a recognized global leader in clinical trial testing and central laboratory services. This edition further brings you the story of some of the most promising clinical trials service companies that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership articles from subject matter experts and exclusive insights from CIOs and CXOs. We hope this edition will provide you with the right assistance in choosing the best clinical trials service according to your requirements.Let us know your thoughts!Stepping into a Future Shaped by DigitalizationCopyright © 2021 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.MAY - 25 - 2021, Vol 07 - Issue 04 (ISSN 2644-2787) Published by ValleyMedia Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comsales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:John GothamTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >